RENBP and atherosclerosis: The targets involved in anti-HF prediction were associated with various signaling pathways, including pathways involved in cancer, lipid and atherosclerosis, serotonergic synapses, chemical carcinogenesis-receptor activation, AGE-RAGE signaling pathway in diabetic complications, and the estrogen signaling pathway.